IP Library Assignment 054869/0599
Patent Assignment
Reel/Frame 054869/0599

Change of Name

Recorded: 2020-12-29 Pages: 3
Assignor
KALOBIOS PHARMACEUTICALS, INC.
Executed: 2017-07-21
Assignee
HUMANIGEN, INC.
533 AIRPORT BOULEVARD, SUITE 400, BURLINGAME, CALIFORNIA, 94010
Covered Property (1)
Anti-EMR1 Antibodies
Patent: 9,045,539 →
Application: 13/480,937 →
Publication: US 2013/0064826
Related Assignments (7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 8, 2012
From: LUEHRSEN, KENNETH; BAER, MARK; BEBBINGTON, CHRISTOPHER R.; MARTINEZ, DAVID
To: KALOBIOS PHARMACEUTICALS, INC.
Reel/Frame 029267/0156 →
Security Interest May 23, 2016
From: KALOBIOS PHARMACEUTICALS, INC.
To: BLACK HORSE CAPITAL, LP
Reel/Frame 038788/0266 →
Security Interest Dec 22, 2016
From: KALOBIOS PHARAMECUTICALS, INC.
To: BLACK HORSE CAPITAL MASTER FUND LTD.
Reel/Frame 041181/0605 →
Release of Security Interest Mar 30, 2018
From: BLACK HORSE CAPITAL MASTER FUND LTD.
To: KALOBIOS PHARAMECUTICALS, INC.
Reel/Frame 045855/0533 →
Release of Security Interest Mar 30, 2018
From: BLACK HORSE CAPITAL MASTER FUND LTD.
To: KALOBIOS PHARAMECUTICALS, INC.
Reel/Frame 045788/0148 →
Security Interest Jul 16, 2019
From: HUMANIGEN, INC.
To: BLACK HORSE CAPITAL MASTER FUND LTD.
Reel/Frame 049769/0067 →
Release of Security Interest Jun 12, 2020
From: BLACK HORSE CAPITAL MASTER FUND LTD.
To: HUMANIGEN, INC.
Reel/Frame 052920/0631 →